Jacobs Levy Equity Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3,817
| Closed | -$56K | – | 1059 |
|
|
2018
Q4 | $56K | Buy |
3,817
+1,902
| +99% | +$27.9K | ﹤0.01% | 955 |
|
|
2018
Q3 | $134K | Sell |
1,915
-825
| -30% | -$57.7K | ﹤0.01% | 956 |
|
|
2018
Q2 | $203K | Buy |
2,740
+2,074
| +311% | +$154K | ﹤0.01% | 953 |
|
|
2018
Q1 | $63K | Buy |
666
+194
| +41% | +$18.4K | ﹤0.01% | 975 |
|
|
2017
Q4 | $61K | Buy |
+472
| New | +$61K | ﹤0.01% | 964 |
|
|
2016
Q4 | – | Sell |
-469
| Closed | -$72K | – | 1072 |
|
|
2016
Q3 | $72K | Sell |
469
-944
| -67% | -$145K | ﹤0.01% | 978 |
|
|
2016
Q2 | $163K | Sell |
1,413
-114
| -7% | -$13.2K | ﹤0.01% | 1043 |
|
|
2016
Q1 | $173K | Buy |
+1,527
| New | +$173K | ﹤0.01% | 986 |
|
|
2015
Q1 | – | Sell |
-199
| Closed | -$107K | – | 893 |
|
|
2014
Q4 | $107K | Buy |
+199
| New | +$107K | ﹤0.01% | 780 |
|